Ra Pharmaceuticals

Pharma

Takeda has reported that Alofisel, which is approved in Japan and the EU, has come up short in a phase 3 trial in complex Crohn’s Perianal Fistulas.

Kevin Dunleavy Oct 19, 2023 8:43am